Patients were treated using a GnRH agonist protocol with recombinant FSH 150 IU/d and randomized from stimulation day 1 to supplementation with hCG : D0 , 0 IU/d ; D50 , 50 IU/d ; D100 , 100 IU/d ; and D150 , 150 IU/d .